Analysis of high gain signal-averaged P/A wave time domain parameters recorded from external leads (SA-ECG) and internal electrograms (SA-IEGM) recorded from three right- and left-intraatrial leads by Głowniak, Andrzej et al.
287www.cardiologyjournal.org
ORIGINAL ARTICLE
Cardiology Journal
2007, Vol. 14, No. 3, pp. 287300
Copyright ' 2007 Via Medica
ISSN 18975593
Address for correspondence: Dr hab. med. Andrzej Kutarski
Department of Cardiology, Medical University
Jaczewskiego 8, 20954 Lublin, Poland
Tel./fax: +48 81 724 41 51
e-mail: a_kutarski@yahoo.com
Received: 28.02.2007 Accepted: 3.04.2007
Analysis of high gain signal-averaged P/A
wave time domain parameters recorded from
external leads (SA-ECG) and internal
electrograms (SA-IEGM) recorded from
three right- and left-intraatrial leads
Andrzej G‡owniak, Andrzej Kutarski, Dorota SzczŒniak and Piotr Ruciæski
Department of Cardiology, Medical University, Lublin, Poland
Abstract
Background: Time-domain analysis of the P-wave in signal-averaged ECG (SA-ECG)
recorded from chest leads is an accepted method for evaluating the inhomogeneity of atrial
excitation, predictive for atrial arrhythmias. The aim of the study was to determine the value of
the SA-ECG technique for intraatrial signal processing. Additional aims were to evaluate the
correlation between SA-ECG parameters (external and intraatrial) and the frequency of atrial
fibrillation recurrences, ongoing antiarrhythmic therapy and LA diameter.
Methods: Recordings were performed in 24 pts during biatrial pacing system implantation.
A surface SA-ECG was obtained from orthogonal leads, and intraatrial signals were recorded
and averaged separately from the right and left atrium. We analyzed standard SA-ECG
parameters (P/A wave duration, RMS20 and LAS5) and the presence of atrial late potentials
(ALP-Pdur > 125 ms and RMS20 < 2.40 mV).
Results and conclusions: Intraatrial SA-ECG provides accurate data for ALP analysis,
mostly due to its improved signal quality and QRS discrimination. P-duration and RMS20
seem to be parameters with good correlation between external and internal SAECG. Intraatrial
SAECG offers a valuable tool to evaluate abnormalities of the final part of atrial excitation.
There are no straight associations between SA-ECG parameters and arrhythmic burden,
ongoing antiarrhythmic therapy and LA diameter. (Cardiol J 2007; 14: 287300)
Key words: signal-averaged ECG, intraatrial signal, P-wave duration, atrial late
potentials, atrial fibrillation
Introduction
For the past 15 years, analysis of time- and fre-
quency-domain parameters of signal-averaged
P-wave has been applied to estimate electrophysi-
ological properties of the atrial wall, which allow the
identification of the group of patients with high risk
of paroxysmal/recurrent atrial fibrillation (AF) [113].
Impaired conduction in main atrial pathways, as well
as the presence of local conduction disturbances in
atrial walls, leads to inhomogeneity of atrial activa-
tion with increased refractoriness dispersion, cre-
ating conditions for re-entrant atrial arrhythmias
[1416]. In the past decade, the recognition of con-
duction disturbances within the atria have become
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particularly important since the new therapeutic
option was introduced  atrial resynchronization
therapy (bifocal right atrial pacing, biatrial pacing)
[1719]. Low signal amplitude, notched and relatively
sluggish onset of the P-wave recorded from orthog-
onal Franks leads, particularly in patients with re-
current atrial arrhythmias, impedes its use as a syn-
chronization trigger in the signal-averaging process.
The use of the R-wave, alternatively, for synchroni-
zation is limited by the variant P-R segment [113].
In patients with interatrial conduction distur-
bances (mainly within Bachmann bundle), the left
atrium is activated with a delay, generating prolon-
gation of the P-wave with its final portion essen-
tially formed by left atrial potential. Therefore, in
signal-averaged electrocardiograms (SA-ECG) re-
corded in such patients, the values of root mean
square voltage of the last 20 ms of the P-wave
(RMS20) and the duration of low amplitude (< 5 µV)
signal (LAS5) reveal the micro oscillations occur-
ring in the left atrium. It is well known that local
conduction disturbances within the right atrium can
have a key role in the pathogenesis of atrial arrhyth-
mias [1316, 20]. The existence of late potentials
(micro oscillations in the final part of atrial activa-
tion) in the right atrium and the possibility of re-
flecting it in classical external Franks leads are still
open questions. According to Keane et al. [21], de-
layed and fractionated conduction within the right
atrium may explain the presence of high-frequency
potentials in the final portion of the P-wave after
the end of the left atrial activation. Furthermore,
there is the question of the existence of micro po-
tentials in the final part of atrial excitation, which
are of such small amplitude that they can be omit-
ted in external leads, and the problem of their pos-
sible influence on atrial arrhythmia pathogenesis.
These doubts raise another question: How long does
the activation of the right and left atrium last, and is
it possible to assess the final part of atrial depolari-
zation in internal leads? In addition, the final ques-
tion: Could atrial potentials selected from one out of
the three intraatrial leads, having higher amplitude
and abrupt acceleration, be appropriate for trigger-
ing the synchronization in signal-averaging process,
given that the leads will remain in a stable position
throughout the recording procedure? All these un-
certainties led us to compose the working hypoth-
esis that the potentials acquired from three intraa-
trial leads, processed with conventional ECG sig-
nal-averaging technique, could be helpful in
answering all these questions.
The dilatation of atria, influencing re-entrant
wavelength, has a considerable role in the perpet-
uation of arrhythmias; concomitant degenerative
lesions additionally give the chance for unidirection-
al blocks to arise [22, 23]. The atrial dilatation, how-
ever, can be a reversible result of tachyarrhythmia
[24, 25]. Opinions on associations between echocar-
diographic patterns of left atrial overload, interatrial
conduction disorders, the presence of micro oscil-
lations in the final portion of atrial depolarization and
the arrhythmic burden are equivocal [5, 2628].
Long-lasting or recurrent atrial arrhythmias
lead to the remodelling phenomenon, characterized
by altered conduction velocity and refractoriness of
atrial tissue [29]. It is still unclear, if, and to what
extent, recurrent arrhythmias have an influence on
local conduction disturbances, by itself most likely
contributing to atrial electrical remodelling. The
effect of such arrhythmias on high gain signal-av-
eraged ECG and internal electrogram (SA-IEGM)
parameters also remains unclear.
Moreover, there is no clear knowledge on the
modifying effect of antiarrhythmic therapy on the
P-wave time- and frequency-domain analysis of
SA-ECG or SA-IEGM. Class I antiarrhythmic drugs,
decreasing conduction velocity, and class III drugs in-
creasing action potential duration and atrial refracto-
riness [30], hypothetically, should influence atrial de-
polarization homogeneity, particularly in patients with
severely impaired conduction within the atria. It could
be anticipated that conduction disturbances will be
increased by aggressive Ic and/or III class drug ther-
apy, with a shift in depolarization homogeneity
(RMS20 values and presence of atrial late potentials
 opinions in literature are equivocal [12, 3033]).
Our study has the following specific aims:
 1) To attempt to use three low-impedance in-
traatrial leads to obtain right and left atrial elec-
trograms to be processed with the conventional
(body surface) signal-averaging technique.
 2) The comparison of parameters (atrial poten-
tial duration, RMS20 and LAS5, atrial late po-
tentials criteria) yielded by analysis of external
(SA-ECG) and intraatrial (SA-IEGM) signals.
 3) To search for correlations between electro-
physiological status of the atria assessed by SA-
ECG and SA-IEGM analysis and the essential
echocardiographic parameters, indirectly re-
vealing atrial wall strain.
 4) An estimation of the influence of antiarrhyth-
mic drugs (class Ic and III) on external and intraa-
trial averaged signal time-domain parameters, and
whether ongoing medication should be taken into
account during the interpretation of parameters.
The ultimate goal of this study was to evaluate
the value of high gain, signal averaged IEGM for the
assessment of atrial electrophysiological features
of atrial activation.
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Methods
Patients
The study was conducted on a group of 24 pts
(15 female, 9 male, mean age 68.8 – 9.97 years)
eligible for permanent biatrial pacing due to symp-
tomatic brady-tachycardia syndrome with additional
indications for atrial resynchronization therapy:
conduction disturbances within the atria (P-wave
duration > 125 ms) and recurrent, symptomatic and
drug-resistant (‡ 3 drugs, including amiodarone)
atrial fibrillation [17]. The underlying condition was
arterial hypertension in 13 pts (54%), ischemic
heart disease in 5 pts (21%), and valvular disease
in 3 pts (12.5%). In the remaining three pts (12.5%),
lone atrial fibrillation was diagnosed.
Arrhythmias
In the studied group, we analyzed the frequen-
cy of AF recurrences according to the Kingma et
al. [35] paradigm. In 7 pts (29.2%) sporadic AF, in
8 pts (33.3%) recurrent AF and in 9 pts (37.5%)
frequent AF was identified.
Antiarrhythmic treatment
Due to a high arrhythmia burden the ongoing
medication was not modified  discontinuation of
treatment could provoke AF episodes thus impeding
the measurement of pacing and sensing conditions.
During the pacemaker implantation procedures, 5 pts
were treated with one drug (amiodarone or propaf-
enone), 8 were on two drugs (propafenone and sota-
lol/amiodarone) and 11 pts (46%) had no ongoing
antiarrhythmic medication.
Procedure
1) Confirmation of arrhythmia type on the ba-
sis of medical documentation. 2) Echocardiograph-
ic study. 3) 12-lead ECG with 25 mm/s speed and
10 mm/1 mV gain plus leads IIII with 100 mm/s
speed 80 mm/1 mV gain. 4) IEGM recording from
RAA and CS, simultaneously with ECG lead II.
5) SA-ECG recording from external orthogonal
leads. 6) SA-IEGM recording from the right and left
atrium separately. Intraatrial signals were obtained
with standard bipolar pacing leads introduced dur-
ing the pacemaker implantation procedure, subse-
quently employed for permanent pacing.
External SA-ECG recording and processing
Equipment constructed in the National Insti-
tute of Cardiology (Warsaw) was applied for signal
recording and processing. It consisted of a micro-
potential amplifier (noise < 1.5 µV in 0.1300 Hz
bandwidth, CMRR > 130 Db), 12-bit A/D converter,
486 CPU PC and software designed for signal-
averaging processes and subsequent analysis of
data. Standard Ag/AgCl electrodes were applied on
carefully cleansed chest skin. The P-wave was de-
rived from three bipolar orthogonal (Frank) leads.
Signals (from each lead) were amplified (× 1000),
passed through a band-pass filter (cut-off frequen-
cy 0.1300 Hz) and digitized by the A/D converter
with a 12-beat accuracy. The signal-averaging proc-
ess was synchronized by the R-wave trigger.
Ectopic beats, if present, were identified and reject-
ed. Approximately 50 beats were averaged and
stored on PC HD. The process was described be-
fore [11].
High-gain SA-ECG P-wave
parameter time-domain analysis
The first stage was to combine filtered (But-
terworth bidirectional filter) and averaged signals
from three leads X, Y and Z to a spatial vector
magnitude (X2 = Y2 + Z2)1/2. The onset and offset
of P-wave were defined as the points at which the
atrial signal exceeded and returned to the 1.5 µV
level, respectively. The following parameters
were measured and calculated automatically:
1) filtered P-wave duration (Pdur), 2) root mean
square voltage of the final 20 ms of filtered
P-wave (RMS20), 3) duration of low amplitude
signal < 5 mV (LAS5). Atrial late potentials (ALP)
were considered positive with Pdur > 125 ms and
RMS20 < 2.4 mV [11].
Intracardiac SA-IEGM recording
and processing
Three bipolar pacing leads were used: a stand-
ard J shaped lead implanted into the right atrial
appendage (RAA) and the second lead was intro-
duced into the coronary sinus (CS). The third lead
(for permanent ventricular pacing) was temporar-
ily placed in the LRA position. The same equip-
ment (as described above) was employed for sig-
nal recording and processing. To obtain right- and
left-atrial signals, intracardiac leads were attached
to the micro-potential amplifier via sterile connec-
tors according to scheme in Figure 1. The right
atrial electrogram was recorded from three com-
bined intraatrial leads X Y Z, and left atrial elec-
trogram from X Y Z leads. The signal from each
lead was augmented and filtered in the same mode
as during external signal recording. The averag-
ing process was synchronized by the A wave trig-
ger. The employed technique was described be-
fore [36, 37].
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High-gain SA-IEGM A wave parameter
time-domain analysis
Intracardiac signals were processed and ob-
tained parameters analyzed in the same way as the
external SA-ECG.
Interatrial conduction evaluation with
IEGM recordings
The internal electrogram (IEGM) was recorded
from the RAA and CS leads connected to a dual-cham-
ber pacemaker via telemetry (Fig. 2), simultaneous-
ly with lead II ECG. The following timing parameters
were determined: 1) P-wave duration in lead II or III
in standard ECG (25 mm/s speed, 10 mm/mV scale),
2) P-wave duration in lead II or III in high resolution
ECG (100 mm/s speed, 20 mm/mV × 4 scale), 3) in-
teratrial conduction time (IACT) measured from the
onset of A wave in RAA signal to the onset of A wave
in CS signal, 4) total atrial activation time (TAAT)
measured from the onset of P-wave in lead II ECG to
the end of atrial activation in the CS signal (Fig. 3).
Echocardiographic examination
Echocardiographic examination was performed
with Hewlett Packard SONOS 100 equipment with
a 2.5 MHz transducer. The anteroposterior dimen-
sion of the left atrium and left ventricle was meas-
ured in the long axis parasternal view. The left ven-
tricular  ejection fraction (LVEF) was calculated
from data acquired in the apical four-chamber view
according to Simpsons method.
Statistical analysis
The results are presented as the mean – stand-
ard deviation. The statistical significance of the
Figure 1. Scheme presenting the connections of intra-
cardiac leads to obtain right atrial (X Y Z) (A) and left
atrial (X Y Z) (B) signals.
Figure 2. Internal electrogram (IEGM) recorded from
the RAA and CS leads connected to a dual-chamber
pacemaker via telemetry.
Figure 3. Values of P-wave duration in standard and
augmented ECG compared to total atrial activation time
(TAAT) in the same patient.
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differences between the groups was evaluated us-
ing the Students t-test and c2 test. Correlation was
estimated using Pearsons r-test for parametric values
and Spearmans rank R-test for nonparametric
values. A p level of < 0.05 was accepted as statisti-
cally significant.
Results
The results are presented in Table 1. The aver-
age P-wave duration in standard ECG was 129 ms;
the same parameter derived from augmented ECG
was 30 ms higher (158 ms). Thus, in the subsequent
analysis, the latter method was applied. Prolonged
averaged values of Pdur (158 ms), IACT (140 ms)
and TAAT (181 ms) confirm the predominance of
atrial conduction disturbances in the examined
group of patients. The duration of the A wave in the
right atrial SA-IEGM was more prolonged (175 vs.
156 ms); the RMS20 lower (1.8 vs. 2.2 mV) and the
low amplitude signal almost twofold (12.9 vs. 6.7 ms)
in comparison to the external SA-ECG. Moreover,
we observed that the duration of the right atrial A
wave in SA-IEGM was 20 ms longer in comparison
to the P-wave duration in external SA-ECG. The
duration of the left (basal right+left) atrial A wave
in SA-IEGM was also noticeably prolonged and vir-
tually equal to the right-atrial (175 ms); the RMS20
was slightly higher (2.3 mV) compared to RA and
equal to the external Franks leads values. The low
amplitude signal was distinctly longer (9.0 vs. 6.7 ms)
in comparison to the external SA-ECG.
The significance of the differences (analysis
of variance and LSD test) in atrial potential dura-
tion and its RMS20 and LAS5 values in SA ECG/
/IEGM recordings is presented in Table 2. The
duration of A wave measured in the SA-IEGM from
RA and LA did not differ, but it must be recognized
that different timings were measured  the on-
set and the ending of LA A wave was recorded
distinctly later in comparison to the RA A wave
timing. There were no significant differences be-
tween the RMS20 of the external P-wave and the
RA A wave, yet the LA A wave RMS20 was sig-
nificantly higher in comparison to RA. This find-
ing may suggest that the LA activation termi-
nates in a more uniform (homogenous) way than
in the right atrium. Correspondingly, the LAS5
values were significantly higher in the RA than
in the LA SA-IEGM and the external SA-ECG,
which can reflect less homogenous termination
of RA potential.
Examinations of mutual correlation
(r Pearsons) between atrial potential dura-
tion, its RMS20 and LAS5 values derived from
external and intraatrial signal-averaged signals are
presented in Table 3. There was a strong correla-
tion between the duration of SA-ECG P-wave and
SA-IEGM A waves in both right and left atria; how-
ever, the external P-wave duration was, on average,
Table 1. General results. Values of ECG, IEGM and SA ECG/IEGM examined parameters.
Parameters No. Aver. Median Min. Max. SD
ECG
Pdur  standard ECG 24 128.5 128.0 105.0 152.0 14.5
Pdur  high resolution ECG 24 157.7 159.0 125.0 199.0 16.0
IEGM
IACT 24 103.7 99.0 55.0 148.0 22.6
TAAT 24 181.5 182.0 144.0 225.0 22.4
High gain SA ECG  external (Franks) leads
Ext. Pdur 24 156.2 155.4 119.3 186.8 16.8
Ext. RMS20 20 2.17 1.96 1.09 3.69 0.76
Ext. LAS5 24 6.68 5.50 0.00 26.70 7.48
High gain SA IEGM  right atrium (RA)
Int. RA Adur 24 174.8 168.8 144.4 224.5 24.1
Int. RA RMS20 23 1.77 1.69 0.75 3.46 0.72
Int. RA LAS5 23 12.91 11.00 0.00 33.00 7.92
High gain SA IEGM  left atrium (LA)
Int. LA Adur 23 175.3 169.6 138.2 237.1 26.7
Int. LA RMS20 15 2.33 1.78 0.98 4.81 1.19
Int. LA LAS5 15 9.01 9.40 0.00 18.80 6.17
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20 ms shorter than in internal recordings. The dif-
ference of mean values indicates that, in spite of
strong correlation (r = 0.7), referred parameters are
not entirely compatible.
The most significant correlation was attained
between the left and right atrial A wave durations
(in IEGM records). There was a significant corre-
lation (r = 0.5) between RMS20 values derived from
external SA-ECG and the right atrial SA-IEGM;
there was no significant correlation between
RMS20 values derived from the external SA-ECG
and left atrial SA-IEGM. There were no associations
between the RMS20 and LAS5 values derived from
the right and left atrial SA-IEGM, which proves
there is no connection between atrial potential ter-
mination patterns in the right and left atria.
Thereafter, we analyzed the relationship
between atrial potential duration and two
basic atrial conduction indicators  IACT and
TAAT (Table 4). There was a significant correlation
between IACT (r = 0.6) along with TAAT (r = 0.8)
and external P-wave duration as well as intraatrial
SA-IEGM A wave duration. Since all the above pa-
rameters reflect the conduction time within the
atria, such an outcome was anticipated. However,
we noticed that the external SAECG P-wave dura-
tion does not reveal atrial activation entirely, since
it is 15 ms shorter than the total atrial activation
Table 3. Examinations of mutual correlation (r Pearsons)  between atrial potential duration, its RMS20
and LAS5 examined in external and intraatrial recordings.
Parameters Leads No. Average SD r(X,Y) t p
P&A wave duration in external External
23
155.9 17.1 0.73 4.965 0.000
and internal leads Int. RA 174.6 24.6
External
23
155.9 17.1 0.77 5.559 0.000
Internal LA 175.3 26.7
Internal RA
23
174.6 24.6 0.94 12.229 0.000
Internal LA 175.3 26.7
RMS20 of P&A wave in external External
12
1.94 0.67 0.61 2.437 0.035
and internal leads Int. RA 1.62 0.58
External
12
1.94 0.67 0.53 1.984 0.075
Internal LA 2.54 1.25
Internal RA
12
1.62 0.58 0.03 0.107 0.916
Internal LA 2.54 1.25
LAS5 of P&A wave in external External
23
6.970 7.51 0.16 0.728 0.475
and internal leads Int. RA 12.91 7.92
External
15
8.38 8.65 0.12 0.446 0.663
Internal LA 9.01 6.17
Internal RA
15
14.56 5.99 0.24 0.878 0.396
Internal LA 9.01 6.17
Table 2. Comparison of atrial potential duration and its RMS20 and LAS5 in recordings obtained from
external (Franks) and intraatrial leads.
Examined N Leads Average SE Analysis                             LSD test
parameters of variance Groups Comparison Aver. SD of P
diff. diff.
S.A. ECG/IEGM 23 Extern. 155.9 3.57 F = 1411.6 1 1 vs. 2 18.7 3.1 0.000
P&A wave 23 Int. RA 174.6 5.13 p = 0.000 2 1 vs. 3 19.4 3.1 0.000
duration 23 Int. LA 175.3 5.56 3 2 vs. 3 0.70 3.1 0.821
S.A. ECG/IEGM 12 Extern. 1.94 0.20 F = 118.6 1 1 vs. 2 0.32 0.30 0.308
P&A RMS20 12 Int. RA 1.62 0.17 p = 0.000 2 1 vs. 3 0.60 0.30 0.059
12 Int. LA 2.54 0.36 3 2 vs. 3 0.92 0.30 0.006
S.A. ECG/IEGM 15 Extern. 8.38 3.59 F = 98.5 1 1 vs. 2 6.18 2.54 0.022
P&A LAS5 15 Int. RA 14.56 11.24 t = 0.000 2 1 vs. 3 0.62 2.54 0.807
15 Int. LA 9.01 5.59 3 2 vs. 3 5.55 2.54 0.037
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time (TAAT). The duration of atrial potential in
SA-IEGM recorded from right and left atria is vir-
tually equal, although it starts earlier in the right
atrium, which indicates that in the two recordings,
the activation of diverse atrial regions is evaluated.
Occurrence of atrial late potential criteria
in external SA-ECG and intraatrial SA-IEGM.
ALP criteria were positive in 79% of pts in external
SA-ECG (Fig. 4), in 96% of pts in the right atrial and
in 86% of pts in the left atrial SA-IEGM (Table 5).
Table 4. Examination of mutual correlation (r Pearsons) between IACT/TAAT and S.A. P/A duration
recorded from external and intraatrial leads.
Pairs of variables No. Average SD r(X,Y) t p
Correlations with IACT IACT
24
103.7 22.6 0.52 2.839 0.009
Ext. Pdur 156.2 16.8
IACT
24
103.7 22.6 0.53 2.910 0.008
Int. RA Adur 174.8 24.1
IACT
23
103.9 23.1 0.63 3.754 0.001
Int. LA Adur 175.3 26.7
Correlations with TAAT TAAT
24
181.5 22.4 0.76 5.471 0.000
Ext. Pdur 156.2 16.8
TAAT
24
181.5 22.4 0.83 7.096 0.000
Int. RA Adur 174.77 24.10
TAAT
23
181.1 22.9 0.89 9.131 0.000
Int. LA Adur 175.3 26.7
Both methods were consistent in 83% of pts; the
presence of ALP in external SA-ECG was always
confirmed by the right atrial SA-IEGM  in 17%
of pts, the opposite phenomenon was observed. It
may be a sign of greater sensitivity of intraatrial SA-
IEGM, or the necessity of different ALP evaluation
criteria. In only in 1 out of 24 pts (4%), was the ALP
in external SA-ECG not confirmed by the left atrial
SA-IEGM; in 9% of pts, an opposite phenomenon was
observed. There was 91% compatibility in the right
and left atrial ALP occurrence, only in 2/24 pts (9%)
was ALP presence in the right atrial SA-IEGM not
confirmed by the left atrial SA-IEGM; the opposite
phenomenon  ALP presence in the left but not in
the right atrium  was not observed. These records
may suggest the leading role of right atrial conduc-
tion disturbances as a background of atrial arrhyth-
mias (Fig. 5).
Correlations between dimensions of the
left atrium, left ventricle, LVEF and basic atrial
activation parameters (P/A wave duration,
RMS20, LAS5) revealed by SA-ECG/IEGM are pre-
sented in Table 6. There was no significant corre-
lation between LA dimension and SA-ECG/IEGM
derived atrial activation parameters. There were
minor correlations between LVDd and P-wave du-
ration (r = 0.53) and RMS20 (r = 0.53); also be-
tween LVEF and P-wave duration (r = 0.47) and
right atrial A wave duration (r = 0.50). These re-
sults suggest that there is neither an association
between LA enlargement nor LV contractility, and
inhomogeneity of atrial activation revealed by the
existence of micro oscillations in its final part.
Correlations between the frequency of
arrhythmia recurrences and basic atrial activation
parameters (P/A wave duration, RMS20, LAS5) re-
vealed by SA-ECG/IEGM are presented in Table 7.
Figure 4. Example of positive and negative atrial late
potentials (ALP).
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Mean values of the P/A wave duration increased along
with the arrhythmic burden but did not differ signifi-
cantly. The opposite tendency was observed in the
RMS20 values, lower (but not significant) in pts with
a high frequency of arrhythmic episodes. There was
no correlation between the arrhythmic burden and
inhomogeneity of atrial activation revealed by the
existence of micro oscillations in its final part.
Correlation between the frequency of
arrhythmia recurrences and ALP occurrence
in the external and intraatrial SA-ECG/IEGM
is presented in Table 8. There was a minor posi-
tive correlation between arrhythmic burden and
ALP occurrence in external SA-ECG but not in in-
traatrial SA-IEGM. These results confirm that there
is no general association between inhomogeneity
of atrial activation and severity of arrhythmia.
Correlations between ongoing anti-
arrhythmic therapy and basic atrial activation
parameters (P/A wave duration, RMS20) revealed
by the SA-ECG/IEGM are presented in Table 9. In
the subgroups of pts non-treated and those treated
with one and two antiarrhythmic drugs, the values
of P/A waves increased ambiguously with no sig-
nificant change in RMS20 values, suggesting no
straight association between antiarrhythmic thera-
py and conduction disturbances or activation inho-
mogeneity within the atria.
Correlation between ongoing antiarrhyth-
mic therapy and ALP occurrence in external
and intraatrial SA-ECG/IEGM is presented in
Table 10. Atrial late potential criteria in the exter-
nal SA-ECG were positive in 54% of the non-treat-
ed pts and in all (100%) pts treated with one or two
antiarrhythmic drugs  the differences were sig-
nificant with positive correlation. Atrial late poten-
tials in intraatrial SA-IEGM were present in virtu-
ally all pts in subgroups with no statistical differ-
ences, which suggests no clear association between
Table 5. Presence of positive atrial late potentials (ALP) criteria in SA-ECG/IEGM recorded from conven-
tional and intraatrial leads.
Leads Ext. lead Int. RA lead Int. LA lead
ALP Yes 19 (79.2%) 23 (95.8) 19 (86.4%)
ALP No 5 (20.8%) 1 (4.2%) 3 (13.6%)
Lack (not available) 0 0 2
All examined 24 (100%) 24 (100%) 22 (100%)
Examination of accordance of ALP appearance
in external and intraatrial leads
ALP in ext. leads vs. ALP in Int RA leads c2 = 3.965; p = 0.046
ALP in ext. leads vs. ALP in int. LA leads c2 = 3,818; p = 0.0500
ALP in Int RA leads vs. ALP in int. LA leads c2 = 6.634; p = 0.010
Figure 5. Signal-averaged electrogram obtained from
external and intraatrial leads in the same patient.
Internal LA SA-ECG
External SA-ECG
Internal RA SA-ECG
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antiarrhythmic therapy and atrial activation inhomo-
geneity.
Discussion
Recognition of atrial conduction disturbances,
an essential substrate of atrial arrhythmias have
become particularly important since the launch of
the new therapeutic option  atrial resynchroni-
zation therapy [1719]. The most comprehensive
data is revealed by electrophysiological study
(EPS), but this invasive and expensive procedure
is neither suitable for a preliminary selection for
atrial resynchronization therapy nor to evaluate its
electrophysiological effects. Analysis of time- and
frequency-domain parameters of signal-averaged
high-gain P-wave introduced 15 years ago brought
great hope, although low signal amplitude and
a relatively sluggish onset of the P-wave recorded
from orthogonal Franks leads complicate the syn-
chronization process [113]. The application of
oesophageal leads to the signal-averaging technique
considerably improved signal quality (mostly its
amplitude), leading to enhanced detection of atrial
refractoriness inhomogeneity (sluggish termination
and micro-oscillations in the final portion of atrial
potential). This provides a more reliable recogni-
tion of the arrhythmia recurrence hazard; howev-
er, the procedure is far less comfortable [3]. The
described oesophageal signal averaging technique
was also applied by the authors [39], though it gave
no prospect to answer the questions put in the in-
troduction (concerning the right atrial potential ter-
mination) since the terminal part of the oesopha-
geal signal originates from the left atrium.
The presented results demonstrated the tech-
nical possibility of using three low-impedance in-
traatrial leads to obtain right and left atrial electro-
grams to be processed with the conventional sig-
nal-averaging technique. Intraatrial SA-IEGM
provided registration of an additional 20 ms of atri-
al activation omitted in external recordings. The ex-
tinction of atrial activation in pts with severe atrial
arrhythmias was less homogenous in the right than
in the left atrium. Moreover, the right atrial
SA-IEGM allows for more frequent identification of
atrial late potentials in comparison to the external
SA-ECG, if the same criteria are applied.
Although atrial dimensions have an important
role in arrhythmia perpetuation [3740], far less is
known about their influence on atrial conduction
disturbances, particularly on the presence of microoscil-
lations in the final part of atrial activation. Fukunami
demonstrated that the P-wave duration in SA-ECGTa
b
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both groups [2]. According to Stafford, atrial dilata-
tion has an influence on the frequency-domain
rather than time-domain SA-ECG parameters [26];
several other authors share this view [24, 28].
Provost emphasizes that the P-wave duration in
SA-ECG and the atrial size have no relation and cor-
respond to independent (electrophysiological and
Table 10. Number of utilized antiarrhythmic drugs
and presence of ALP in external and internal
leads.
Parameters Presence of ALP
Exten. lead Int. RA lead Int. LA lead
0 6/11 (54.6%) 10/11 (90.9%) 9/11 (81.8%)
1 5/5 (100.0%) 5/5 (100.0%) 4/4 (100.0%)
2 8/8 (100.0%) 8/8 (100.0%) 6/7 (85.7%)
c2 7.464 1.233 0.827
p 0.0239 0.539 0.661
Table 9. Number of utilized antiarrhythmic drugs and P/A wave duration and RMS20 in external and
intraatrial leads.
Leads No. Average (SD)
P/A wave duration      RMS20
Extern. Int RA Int. LA Extern. Int RA Int. LA
0 11 149.6 (19.3) 168.3 (24.6) 171.6 (39.9) 2.39 (0.84) 1.81 (0.72) 2.06 (1.56)
1 5 163.2 (15.3) 187.0 (24.4) 184.4 (22.0) 2.33 (0.97) 2.09 (0.87) 2.29 (1.13)
2 8 160.9 (11.7) 176.0 (23.0) 174.6 (24.4) 1.87 (0.51) 1.51 (0.61) 2.54 (1.07)
Analysis of variance F 1.701 1.065 0.380 1.015 1.018 0.213
p 0.206 0.362 0.688 0.383 0.379 0.811
ASD test comparison 0 vs. 1 0.135 0.162 0.395 0.884 0.479 0.802
of three groups 0 vs. 2 0.150 0.493 0.824 0.204 0.400 0.527
2 vs. 3 0.805 0.430 0.546 0.309 0.174 0.783
Table 7. P duration and its RMSA20 and AF severity.
AF severity (freq. No.                      Average (SD)
of recurr.)  Leads P duration RMS20
Extern. Int. RA Int. LA Extern. Int. RA Int. LA
Sporadic (S) (monthly) 7 148.9 (18.2) 164.8 (12.1) 164.8 (14.7) 2.50 (0.82) 1.88 (0.73) 2.31 (1.37)
Recurrent (R) (weekly) 8 154.4 (18.2) 168.4 (18.4) 172.7 (30.9) 2.26 (0.69) 1.86 (0.73) 2.67 (1.57)
Frequent (F) (daily) 9 163.4 (13.2) 188.2 (30.5) 185.5 (29.2) 1.91 (0.82) 1.60 (0.75) 2.17 (1.08)
Analysis of variance F 1.587 2.611 1.265 0.884 0.353 0.202
p 0.229 0.097 0.304 0.431 0.707 0.819
LSD test S vs. R 0.526 0.758 0.582 0.618 0.967 0.718
S vs. F 0.096 0.051 0.134 0.226 0.489 0.876
R vs. F 0.276 0.084 0.346 0.372 0.480 0.537
Table 8. Severity of AF and presence of ALP in
external and intraatrial RA and LA recordings
of SA ECG/IEGM during the study.
AF severity Leads
(freq. of recurr.) Extern. Int. RA Int. LA
Sporadic (monthly) 4/7 7/7 6/6
(57.1%) (100%) (100.0%)
Recurrent (weekly) 6/8 7/8 5/7
(75.0%) (87.5%) (71.4%)
Frequent (daily) 9/9 9/9 8/9
(100%) (100%) (88.9%)
All 19/24 23/42 19/22
(79.2%) (95.8%) (86.4%)
c2 4.511 2.087 2.322
p  0.104 0.352 0.313
was significantly increased in pts with recurrent
atrial fibrillation in comparison to healthy subjects,
regardless of the similar left atrial dimensions in
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anatomical) substrates [27]. Buncova explains in-
creased LA dimension and SA-ECG P-wave duration
in pts after long-lasting atrial fibrillation with the re-
modelling phenomenon [28], which corresponds with
further observations. The prolonged P-wave and
slight atrial dilatation are consequences of arrhyth-
mia rather than the cause of it. With this knowledge,
the interpretation of the findings in pts shortly after
the termination of the long-lasting atrial arrhythmia
must be carried out cautiously. In our study we dem-
onstrated that although there is a weak correlation
between echocardiographical indices of LV function
and SA-ECG/IEGM parameters reflecting atrial con-
duction disorders (P/A wave duration), there is no cor-
relation between the left atrium size and homogeneity
of atrial potential termination (RMS20 and LAS5 pa-
rameters). We can ascertain that the left atrium size
has a negligible influence on atrial conduction dis-
turbances, and our results confirm the hypothesis
that conduction disorders within the atria are inde-
pendent of the left atrial dimensions [2, 5, 27, 28].
Prolonged or recurrent atrial fibrillation leads
to the remodelling phenomenon (a shift in conduc-
tion velocity and refractoriness of atrial tissue), thus
fibrillation itself becomes the cause of arrhythmia
and this explains the conversion from paroxysmal
to chronic AF [29]. There are a few articles analyz-
ing the relationship between the arrhythmic burden
and time-domain parameters of SA-ECG P-wave.
Michelicci demonstrated that there is no difference
in the P-wave triggered SAECG time- and frequen-
cy-domain parameters between the groups of pts
with frequent (‡ 2 episodes per year) and non-fre-
quent (< 2 episodes per year) lone paroxysmal atrial
fibrillation [5]. Opolski et al. [6] and Raitt et al. [12]
observed prolonged SA-ECG P-wave duration in pts
with early AF recurrence after DC cardioversion.
Kurogouchi demonstrated significantly increased
P-wave duration and decreased RMS20 values in pts
directly after arrhythmia termination and an im-
provement or normalization of analyzed parameters
in the 3 months follow up, not followed by normal-
ization in left atrium size [43]. Thereafter, time-
domain parameters of the P-wave in SA-ECG ap-
pear to disclose not only the substrate of arrhyth-
mia but also its (possibly reversible) consequences.
The presented results demonstrated that even
though there is a weak correlation between the ar-
rhythmic burden (evaluated by rate of recurrence)
and SA-ECG/IEGM parameters reflecting the de-
gree of interatrial conduction disturbances (P/A
wave duration), there is still no general association
between severity of arrhythmia and inhomogenei-
ty of atrial activation (reflected by micro-oscillations
in the terminal part of atrial activation) in the group
of pts selected for atrial resynchronization thera-
py. We must remember, on the other hand, that in
some pts, drug-resistant arrhythmia may result
from an existing focal trigger  frequently local-
ized in pulmonary vein ostia [40].
When analyzing time- and frequency-domain
parameters of signal-averaged P-wave in pts after
the termination of atrial fibrillation, we must con-
sider ongoing antiarrhythmic therapy, since there
are numerous studies revealing the effect of AA
drugs on the SA-ECG P-wave [3033]. Ic class AA
drugs, slowing down conduction within the atria,
and III class, prolonging action potential and refrac-
tory period [30], should, hypothetically, have an in-
fluence on the homogeneity of atrial potential ter-
mination, particularly in pts with atrial conduction
disorders. Stafford confirmed that III class AA drugs
do not prolong the P-wave duration, but only in-
crease the atrial refractory period, which is not re-
flected in SA-ECG P-wave parameters [31]. Hab-
erl et al. [32] demonstrated that sotalol decreased
the P-wave amplitude with an ambiguous influence
upon its duration. Igarhasi et al. [33] demonstrated
that flecainide prolongs P-wave duration, with no
significant influence on RMS20 and LAS5 values.
Procainamide had no apparent influence on SA-ECG
P-wave parameters  the author assumes that the
analysis of P-wave duration can be applied to assess
the risk of AF recurrence regardless ongoing an-
tiarrhythmic therapy. A contradictory opinion was
presented by Raitt et al. [12], who believes that the
P-wave duration can be a predictor of arrhythmic
hazard only in pts without antiarrhythmic therapy
since it reflects mostly atrial dilatation and conduc-
tion velocity but not atrial refractoriness. Its prolon-
gation (a typical effect of class III antiarrhythmic
drugs) significantly reduces the incidence of arrhyth-
mia, regardless of abnormal SA-ECG P-wave param-
eters. Redfearn demonstrated that flecainide slows
down conduction velocity, the adaptation of the re-
fractory period to the heart rate, prolongs the
P-wave duration and reduces its spectral energy [34].
Analysis of the presented data confirmed no
straight association between antiarrhythmic thera-
py and conduction disturbances (P/A wave duration)
or activation inhomogeneity (RMS20 and LAS5)
within the atria assessed by SA-ECG/IEGM param-
eters. Some weak associations revealed in the study,
in our opinion, are determined by the electrophysi-
ological background and secondary arrhythmia es-
calation rather than the antiarrhythmic treatment.
The presented literature and our results sug-
gest that analysis of the time- and frequency-domain
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P-wave parameters in high gain, signal-averaged
electrograms in pts with recurrent atrial arrhyth-
mia reveal not only morphological changes in the
atria with consequent local conduction disorders,
but also the haemodynamic status (atrial wall strain)
and the effects of prolonged arrhythmia (atrial re-
modelling) and ongoing antiarrhythmic medication.
Limitations of the study
The signal-averaging process was triggered
by the R-wave, since P-wave synchronization was
inadequate in pts with fragmented, low-amplitude
P-wave, frequent in the studied group. The echocar-
diographic examination was restricted merely to
essential parameters. The applied left atrial lead
system is not purely left atrial  the introduction
of a multipolar catheter to the left atrium via trans-
septal approach and selection of three bipolar leads
would be a better option. It is a routine procedure
in pulmonary vein ectopy mapping and ablation but
not during pacemaker implantation. In the study
group there were no indications for left heart cath-
eterization; therefore, we applied a pacing electrode
introduced to the coronary sinus connected to the
tip and ring of the electrode placed in the low right
atrium. Consequently, in the left atrial leads, the
activation of the lower part of the right atrium was
additionally recorded. Since the final part of the left
atrial excitation has superior importance, we con-
sider this solution satisfactory.
At the start of the study, there was some
doubt whether the fragmented termination of the
potential recorded from the right atrium truly
reflects right atrial activation or just a far field
sensing from the left atrium. However, parallel
recordings performed during left atrial and bia-
trial pacing confirmed the existence of what were
clearly right atrial late potentials, since the left
atrium was activated earlier during pacing [41, 42].
The study was performed in the selected group
of patients with recurrent atrial arrhythmia and
considerable conduction disturbances within the
atria, thus our conclusions must not be applied to
the general population of patients with paroxys-
mal atrial fibrillation.
Conclusions
1. There is a technical possibility to obtain aver-
aged signals from the right and left atria sepa-
rately by means of the conventional technique
designed for external high-gain signal-averaged
ECG recording. By this means, an additional
20 ms of atrial potential is registered, suggest-
ing superior scientific and diagnostic potential.
2. The right atrial SA-IEGM allows for more fre-
quent ALP recognition in comparison to exter-
nal SA-ECG, with the same criteria applied.
3. The termination of right atrial activation in pa-
tients with interatrial conduction disturbances
and recurrent atrial fibrillation is less homog-
enous compared to the left atrium.
4. Although there is a weak correlation between
echocardiographic indices of LV function and
SA-ECG/IEGM parameters reflecting atrial
conduction disorders (P/A wave duration),
there is no correlation between LV function
indices and the homogeneity of atrial potential
termination.
5. Although there is a weak correlation between
the arrhythmic burden (evaluated by rate of re-
currence) and SA-ECG/IEGM parameters re-
flecting the degree of interatrial conduction dis-
turbances (P/A wave duration), there is no clear
association between the severity of arrhythmia
and inhomogeneity of atrial potential termination
6. There is no direct association between an-
tiarrhythmic therapy and conduction distur-
bances (P/A wave duration) or activation inho-
mogeneity (RMS20 and LAS5) within the atria
assessed by SA-ECG/IEGM parameters.
7. The differences in P/A wave duration in
SA-ECG and intraatrial SA-IEGM with diverse
homogeneity of atrial potential termination in
right and left atria, as well as limitations of
external Frank leads SA-ECG, indicate that the
investigation of intraatrial three-lead SA-IEGM
may be a valuable diagnostic tool e.g. for com-
parative analysis of different atrial pacing
modes.
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